Bard C R Inc (BCR) Return on Investment ROI from the third quarter of 2017 to third quarter of 2016 and for the year 2017, average high and low, overall ranking from Sep 30 2017 to Sep 30 2016 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bard C R Inc  (BCR)


Bard C R Inc's ROI from its third quarter of 2017 to the third quarter of 2016 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bard C R Inc's ROI in the third quarter of 2017?
Bard C R Inc achieved a return on average invested assets (ROI) of 14.47 % in its third quarter of 2017, which is below Bard C R Inc's average return on investment, which stands at 14.64%.

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2017.

Within the Healthcare sector 61 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2017 from 193 to 488.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2017)
III. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter
Y / Y Investment Change TTM 3.1 % 10.99 % 4.95 % 3.06 % -5.21 %
Y / Y Net Income Change TTM 12.66 % 76.61 % 255.86 % 954.87 % -
Investment (TTM) in Millions 4,073 3,839 3,685 4,197 4,436
Return On Investment (TTM) 14.47 % 14.21 % 15.06 % 13.4 % 13.25 %
BCR's Overall Ranking # 488 # 193 # 218 # 0 # 0
Seq. Investment Change TTM -2.25 % 2.67 % -0.62 % 3.37 % 5.24 %
Seq. Net Income Change TTM -0.4 % -3.16 % 11.67 % 4.59 % 56.14 %
Net Income (TTM) in Millions 572 574 592 531 507

BCR Company Profile >> Back to BCR Roi Comparisons >> See Annual BCR Return On Investment



Return On Investment BCR's Ranking
Within: No.
Industry # 20
Sector # 62
Overall # 488

Return On Investment Statistics
High Average Low
20.33 %
14.64 %
2.98 %
(Sep. 28, 2009)   (Mar 31 2016)







Financial Statements
Bard C R Inc's III. Quarter Investments $ 4,073 Millions BCR's Balance sheet
Bard C R Inc's III. Quarter Income $ 94 Millions Quarterly BCR's Income Statement
BCR's Income by Division See BCR's Income by Division


BCR Annual Return On Investment (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (FY 2014)
(Dec. 31. 2014)		 (Dec 31 2013)
2013		 (FY 2012)
(Dec. 31. 2012)
Total Investments in Millions 4,197 3,681 4,478 4,455 3,704
Y / Y Investment Growth 14.02 % -17.8 % 0.53 % 20.27 % 22.36 %
Net Income in Millions 531 135 295 690 530
Y / Y Net Income Growth 292.47 % -54.02 % -57.31 % 30.13 % 61.62 %
Annual Return On Investment 12.66 % 3.68 % 6.58 % 15.49 % 14.31 %


Annual Roi Comment
In the fiscal year 2016 ROI improved to 12.66 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BCR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BCR's Competitors
Subscribers only: Roi for Bard C R Inc's Suppliers
Subscribers only: Return On Investment for BCR's Customers

Other Ratios
BCR's Roa BCR's Inventory Turnover Ratio BCR's Growth Rates BCR's Dividend Statistics
BCR's Profitability Ratios BCR's Asset Turnover Ratio BCR's Dividend Growth
BCR's Roe BCR's Valuation Ratios BCR's Financial Strength Ratios BCR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2017, within Healthcare Sector ROI
Cba Florida Inc   37.72 %
Exelixis Inc   36.99 %
Luna Innovations Inc  34.62 %
Cryo cell International Inc   32.21 %
Iveric Bio Inc   29.71 %
Psychemedics Corporation  29.64 %
Innoviva Inc   28.25 %
Remedent Inc   26.57 %
Opiant Pharmaceuticals Inc   26.28 %
Mettler toledo International Inc   25.98 %
Idexx Laboratories Inc  25.26 %
United Therapeutics Corporation  25.07 %
Align Technology inc   24.91 %
Nrc Health  24.00 %
Alpha Pro Tech Ltd   23.24 %
Supernus Pharmaceuticals inc   22.94 %
Gilead Sciences Inc   22.51 %
Lineage Cell Therapeutics Inc   21.72 %
3m Company  19.80 %
Healthcare Services Group Inc   19.31 %
Tivity Health Inc   19.21 %
Atrion Corporation  18.69 %
Regeneron Pharmaceuticals Inc   18.67 %
Biogen Inc   18.43 %
Intuitive Surgical Inc   18.22 %
Oramed Pharmaceuticals Inc  18.14 %
Sanara Medtech Inc   18.14 %
Cutera Inc   17.96 %
Illumina Inc   17.73 %
Cambrex Corp  17.64 %

Date modified: 2026-09-08T15:08:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.